All Events

Otology and Emerging Genetic Treatments

This GGR is in collaboration with the International Federation of ORL Societies (IFOS)

Otology and Emerging Genetic Treatments
Otology and Emerging Genetic Treatments

The AAO-HNSF is proud to host this Global Grand Rounds Webinar in collaboration with the International Federation of ORL Societies (IFOS)

In this complimentary session, open to all members of the ENT community, esteemed panelists from around the world will discuss practical management strategies, evolving evidence, and “real-world” decision-making within the burgeoning field of molecular otology.

Distinguished Panelists:

  • Carleton Eduardo Corrales, MD
    Harvard Medical School; Brigham and Women’s Hospital, Boston, Massachusetts, United States
    Regeneron Trial Results, DBOTO Findings & Surgical Innovation
  • Hubert Löwenheim, MD, PhD
    University of Tübingen – The University Hospital, Tübingen, Germany
    The Road Here: From Friedrich Miescher to Clinical Trials
  • Lawrence R. Lustig, MD
    Columbia University Medical Center, New York, New York, United States
    Building the Bridge: The Preclinical Mouse Data and the Path to the Clinic
  • Yilai Shu, MD, PhD
    Eye & ENT Hospital of Fudan University, Shanghai, China
    International Expert Consensus on Gene Therapy for Hereditary Hearing Loss: Based on Clinical Trials

Moderators:

  • Soha Ghossaini, MD
    Intent Medical Group Endeavor Health Advanced Neurosciences Center, Chicago, Illinois, United States
  • Hernan Goldsztein, MD
    Pacific ENT Medical Group, San Diego, California, United States
Register today at no cost here.
When

Add to your Calendar
Where

Virtual

Contact

[email protected]

Register for Event
No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.